Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 1-10 of 74

Page
per page
  1. BIIB021
    A4058 BIIB021
    Target: HSP90
    Summary: Hsp90 inhibitor,selective and competitive
      insoluble in EtOH; insoluble in H2O; ≥14.95 mg/mL
  2. PF-04929113 (SNX-5422)
    A4065 PF-04929113 (SNX-5422)
    Target: HSP90
    Summary: Hsp90 inhibitor,potent and selective
      ≥23.85 mg/mL
  3. Deltarasin
    A3358 Deltarasin
    Target: Phosphodiesterases (PDEs)
    Summary: KRAS-PDEδ interaction inhibitor
      Soluble in DMSO
  4. INCB024360 analogue
    A3493 INCB024360 analogue
    Summary: potent and selective inhibitor of IDO1
      ≥13.55 mg/mL
  5. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: CETP inhibitor,potent and selective
      ≥32.1 mg/mL
  6. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  7. IPI-504 (Retaspimycin hydrochloride)
    A4061 IPI-504 (Retaspimycin hydrochloride)
     3 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor,novel, potent,selective
      ≥26.1 mg/mL
  8. AUY922 (NVP-AUY922)
    A4057 AUY922 (NVP-AUY922)
     1 Citation
    Target: HSP90
    Summary: Potent Hsp90 inhibitor
      ≥23.27 mg/mL
  9. SNX-2112
    A4068 SNX-2112
     1 Citation
    Summary: Hsp90 inhibitor,ATP-competitve,potent and selective
      ≥23.05 mg/mL
  10. KW-2478
    A4062 KW-2478
    Target: HSP90
    Summary: Potent Hsp90 inhibitor, novel, non-ansamycin,
      ≥100 mg/mL

Items 1-10 of 74

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. 5-alpha Reductase 1 item
  2. 5-Lipoxygenase 1 item
  3. C14ɑ demethylase 1 item
  4. Carbonic Anhydrase 3item
  5. CETP 1 item
  6. Cholesterol absorption 1 item
  7. CYP3A/CYP450 3item
  8. Dehydrogenase 5item
  9. DHFR 1 item
  10. Dopamine β-hydroxylase 3item
  11. FAAH 1 item
  12. Factor Xa 1 item
  13. Ferroptosis 1 item
  14. HMG-CoA Reductase 5item
  15. HSP 8item
  16. IDO 4item
  17. KRAS-PDEδ 1 item
  18. Lipid Metabolism 1 item
  19. Oxidative Phosphorylation 1 item
  20. P450 3item
  21. PDE 14item
  22. Phospholipase 2item
  23. TPH 3item
  24. Transferase 7item
  25. Hydrolase 2item
Specificity
  1. Selective 42item
  2. Non-Selective 1 item
Reversibility
  1. Irreversible 3item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 12item
  4. Thymidylate Synthase 1 item
  5. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  6. HSP90 6item
  7. Cytochrome P450 (CYP450) 6item
  8. HMG-CoA Reductases 4item
  9. DGAT 1 item
  10. Pyruvate dehydrogenases (PDH) 1 item
  11. CETP 1 item
  12. Lactate Dehydrogenases (LDH) 2item
  13. Nampt 1 item
  14. Carbonic Anhydrases 3item
  15. Aldehyde Dehydrogenases 1 item
  16. Phospholipases 1 item
  17. Catechol O-Methyltransferase (COMT) 1 item
  18. Hydroxylases 1 item
  19. FPTase 1 item
  20. Tryptophan hydroxylases (TPH) 2item
  21. sodium channel 1 item
  22. Ftase 1 item
  23. PC-PLC 1 item
  24. HMGCR 1 item
  25. adrenergic receptor 1 item
  26. sterol demethylase 1 item
  27. GAPDH 1 item
  28. complex I of the mitochondrial electron transport chain 1 item
  29. potassium channel 1 item
  30. calcium channel 1 item
  31. FAAH 1 item
  32. carnitine reabsorption 1 item
  33. 5-alpha Reductases 1 item
  34. DHFR 1 item
  35. GARFT 1 item
  36. glutathione peroxidase 4 1 item
  37. S-adenosylhomocysteine hydrolase 1 item
  38. IDO 1 item
  39. Tph 1 item
  40. epoxide hydrolase 1 item
  41. Cholesterol absorption 1 item
  42. Glycogen Phosphorylases 1 item
Related Disease
  1. Acne 1 item
  2. Acute Kidney Injury 1 item
  3. Acute Myeloid Leukemia 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 6item
  8. Cancer 24item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Cocaine-Related Disorders 2item
  11. Colon Cancer 1 item
  12. Diabetes 2item
  13. Dyslipidemia 1 item
  14. Epilepsy 1 item
  15. Erectile Dysfunction 3item
  16. Fungi 1 item
  17. Glioblastoma 1 item
  18. Glioma 1 item
  19. HIV Infections 1 item
  20. Hypercholesterolemia 1 item
  21. Inflammation 1 item
  22. Inflammatory Diseases 1 item
  23. Kidney Injury Studies 1 item
  24. Leukemia 1 item
  25. Lung Cancer 2item
  26. Lymphoma 1 item
  27. Melanoma 3item
  28. Multiple Myeloma 2item
  29. Neuroblastoma 2item
  30. Neurocognitive Disorders 1 item
  31. Non-small Cell Lung Cancer 1 item
  32. Obsessive-Compulsive Disorder 1 item
  33. Osteoporosis 1 item
  34. Pancreatic Cancer 2item
  35. Pancreatic Carcinoma 1 item
  36. Prostate Cancer 7item
  37. Psoriasis 2item
  38. Psoriasis Vulgaris 1 item
  39. Rheumatoid Arthritis 1 item
  40. Schizophrenia 1 item